A manufacturer-funded study found a significant decrease in annual total medical costs in patients with overweight/obesity ...

SAN ANTONIO — Oral semaglutide 25 mg appears to be just as effective in promoting weight loss and other beneficial outcomes ...

A new joint study by the University of Eastern Finland and Karolinska Institutet in Sweden found that the GLP-1 agonists ...

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

Effective treatments for alcohol dependence exist; however, they remain underused and are not effective, or suitable, for all ...

The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

"In the case of oral semaglutide for overweight/obesity, it appears that 25 mg a day is that dose." The trial enrolled 243 participants with a BMI of at least 30, or 27 with a weight-related ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...

For patients with type 2 diabetes mellitus, semaglutide is associated with a reduced risk for a first-time Alzheimer disease (AD) diagnosis compared with other antidiabetic medications.

Once-weekly semaglutide shows significant reduction in knee osteoarthritis pain and body weight in adults with obesity, a ...